These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13704588)

  • 21. Multiple myeloma (large cell type) in a 24-year-old woman with normal total protein and latent electrophoretic changes.
    BLAUSTEIN A; CHRYSSANTHOU CP
    Can Med Assoc J; 1958 Oct; 79(8):654-7. PubMed ID: 13585289
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of paper electrophoresis & reticuloendothelial index in myeloma].
    SANDOR G; LEVY M
    Ann Biol Clin (Paris); 1958; 16(1-2):97-102. PubMed ID: 13509259
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contribution to paraproteinemic coma].
    KIRCHMAIR H; GABL F
    Dtsch Med Wochenschr; 1960 Nov; 85():2025-6 passim. PubMed ID: 13756204
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood proteins in various forms of leukemia and myelomatous diseases].
    AKKERMAN VV; MOISEEVA VP
    Klin Med (Mosk); 1958 Jul; 36(7):106-12. PubMed ID: 13576710
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complete data on 85 cases of Kahler's disease by quantitative & qualitative studies on blood proteins].
    FAUVERT R; HARTMANN L; MALLARME J; BOIVIN P
    Rev Prat; 1959 Jun; 9(16):1749-52 passim. PubMed ID: 13668320
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dysproteinemic conditions in myeloma and myelomatous conditions].
    Arcangeli M
    Cancro; 1967; 20(1):56-66. PubMed ID: 5609396
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extramedullary plasmacytoma; blood protein changes & their diagnostic value; case report].
    GUERRA ROUSSEAU R; VIDAL R; BIDOT C; SUAREZ FERNANDEZ JM
    Arch Cuba Cancerol; 1957; 16(10-12):413-9. PubMed ID: 13509987
    [No Abstract]   [Full Text] [Related]  

  • 28. [Demonstration of the synthesis of blood paraproteins by plasmacytes, using uniformly C-14-labeled glucose].
    SONNET J; GILLANT G; SOKAL G
    Rev Belg Pathol Med Exp; 1958 Jun; 26(5):313-24. PubMed ID: 13658700
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypoproteinemia in plasmocytoma].
    DAHM K
    Medizinische; 1958 Jan; 2(3):125-7. PubMed ID: 13516229
    [No Abstract]   [Full Text] [Related]  

  • 30. [Behavior of C-reactive protein in plasmocytoma].
    GEYER G
    Wien Med Wochenschr; 1958 Nov; 108(47):1051-2. PubMed ID: 13616370
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contribution to biochemical characteristics of myelomas].
    DYRHON V; RYBAK M; DYRHONOVA V
    Cas Lek Cesk; 1961 Jun; 100():724-7. PubMed ID: 13725407
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood protein disorders plasmacytoma; differences in the results of different methods of protein analysis].
    POLIMENI R
    Rass Fisiopatol Clin Ter; 1958 Apr; 30(4):260-80. PubMed ID: 13554903
    [No Abstract]   [Full Text] [Related]  

  • 33. [Protein studies and clinical observations in plasmocytoma patients].
    LEY H
    Z Klin Med; 1954; 151(4):367-81. PubMed ID: 13188196
    [No Abstract]   [Full Text] [Related]  

  • 34. [Atypical characteristics of the serum protein picture in two cases of plasmocytoma].
    LEVI G; ALMICI C
    G Clin Med; 1958 Jun; 39(6):990-1000. PubMed ID: 13574556
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dysproteinemia preceding the clinical appearance of multiple myeloma of the bone].
    LENG-LEVY J; DAVID-CHAUSSE J; DU PASQUIER P; MESNIER F
    J Med Bord; 1958 Sep; 135(9):921-6. PubMed ID: 13588248
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response.
    Katodritou E; Ganz T; Terpos E; Verrou E; Olbina G; Gastari V; Hadjiaggelidou C; Varthaliti M; Georgiadou S; Westerman M; Zervas K
    Am J Hematol; 2009 Aug; 84(8):524-6. PubMed ID: 19536845
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-2-microglobulin in multiple myeloma.
    Musarurwa C; Matarira HT
    Cent Afr J Med; 2004; 50(1-2):19-20. PubMed ID: 15490720
    [No Abstract]   [Full Text] [Related]  

  • 38. [On various aspects of the humoral picture and of its pathological repercussions on the tissues in plasmocytomatous disease (based on 18 personally observed cases)].
    PENDE G; GHIGLIOTTI G; ASTENGO F; AZZENA D
    Arch Maragliano Patol Clin; 1959; Suppl 24():1-120. PubMed ID: 13734081
    [No Abstract]   [Full Text] [Related]  

  • 39. [Properties and composition of serum albumin in multiple myeloma].
    CAPUTO A
    Z Krebsforsch; 1955; 60(3):372-8. PubMed ID: 14386976
    [No Abstract]   [Full Text] [Related]  

  • 40. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
    Tichý M; Maisnar V; Palicka V; Friedecký B; Vávrová J; Novotná H; Cermáková Z; Dastych M; Cechák P; Vogtová D; Jarolímková E; Benáková H; Hachová L; Bezdícková D; Kouril F; Zábranská EA; Zenková J; Slabý P; Scudla V; Gregora E; Spicka I; Straub J; Schützova M; Hájek R
    Neoplasma; 2006; 53(6):492-4. PubMed ID: 17167717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.